Liu Jian-dong, Du Tong-hai, Liu Li-yan, Wei Wen-jie
Department of Surgery, Bejing Puren Hospital, Beijing 100062, China.
Zhonghua Wei Chang Wai Ke Za Zhi. 2005 Jul;8(4):297-300.
To compare the long-term efficiency between preoperative radiotherapy or radiochemotherapy followed by lower-anterior resection and abdominoperineal resection (APR) for lower and locally advanced rectal cancer.
From January 1983 to December 2000, 157 consecutive patients suffering from lower rectal cancer were enrolled in the study, which included 69 cases of clinical stage II and 88 cases of stage III respectively. All patients were divided in to three groups. Patients in group A (n=52) received preoperative radiotherapy with a total dose of 35-45 Gy within 4-5 weeks plus preoperative chemotherapy with 5-fluorouracil (5- FU) followed by lower-anterior resection; patients in group B (n=51) received radiotherapy followed by lower-anterior resection; patients in group C (n=54) received APR only. Clinical data of all patients were reviewed retrospectively.
The follow-up rate was 91.7%. The 5- year survival rate was higher in group A (71.1%) than those in group B (47.1%) and group C (42.6%)(P< 0.05). The tumor- free survival rate was higher in group A (61.5%) than those in group B (37.3%) and group C (35.2%)(P< 0.05). The local recurrence rate was 13.5%, 15.7% and 11.1% in group A, B and C respectively, there was no significant difference in recurrence rate among three groups (P> 0.05). The distant metastasis rate was lower in group A (23.1%) than those in group B (49.0%) and group C (46.3%)(P< 0.05), but there was no significant difference in distant metastasis rate between group B and group C.
The combined preoperative radiochemotherapy followed by lower-anterior resection can improve the 5-year survival rate and tumor-free survival rate, and decrease distal metastasis rate.
比较术前放疗或放化疗后行低位前切除术与腹会阴联合切除术(APR)治疗低位及局部进展期直肠癌的长期疗效。
1983年1月至2000年12月,157例低位直肠癌患者连续纳入本研究,其中临床Ⅱ期69例,Ⅲ期88例。所有患者分为三组。A组(n = 52)患者接受术前放疗,4 - 5周内总剂量35 - 45 Gy,加用5 - 氟尿嘧啶(5 - FU)术前化疗,随后行低位前切除术;B组(n = 51)患者接受放疗后行低位前切除术;C组(n = 54)患者仅接受腹会阴联合切除术。回顾性分析所有患者的临床资料。
随访率为91.7%。A组5年生存率(71.1%)高于B组(47.1%)和C组(42.6%)(P < 0.05)。A组无瘤生存率(61.5%)高于B组(37.3%)和C组(35.2%)(P < 0.05)。A、B、C组局部复发率分别为13.5%、15.7%和11.1%,三组复发率差异无统计学意义(P > 0.05)。A组远处转移率(23.1%)低于B组(49.0%)和C组(46.3%)(P < 0.05),但B组和C组远处转移率差异无统计学意义。
术前放化疗联合低位前切除术可提高5年生存率和无瘤生存率,并降低远处转移率。